Fjord Pharmaceuticals IVS
CVR 38367188 · Entrepreneurial company (IVS) · Dissolved after bankruptcy
Fjord Pharmaceuticals IVS is a Entrepreneurial company (IVS), founded on , based in Vanløse. The company is registered in the industry fremstilling af farmaceutiske præparater. Fjord Pharmaceuticals IVS went bankrupt on – 4.0 years after it was founded. 2 annual reports have been published. The latest annual report (31 Dec 2018) shows equity of DKK -7,019 and a net result of DKK 636.
Bankruptcy
- Bankruptcy date
- Status
- Dissolved after bankruptcy
- First distress status
- Being compulsorily dissolved from
- Age at bankruptcy
- 4.0 years
Company details
- CVR number
- 38367188
- Status
- Dissolved after bankruptcy
- Company type
- Entrepreneurial company (IVS)
- Founded
- Ceased
- Address
- Morsøvej 44
2720 Vanløse - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 2
- Auditor
- Grant Thornton, Statsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -9.2% |
| Current ratio | 92% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2018 | 2017 |
|---|---|---|
| Gross profit | DKK -231 | DKK -3,701 |
| Net profit | DKK 636 | DKK -7,655 |
| Equity | DKK -7,019 | DKK -7,653 |
| Total assets | DKK 76k | DKK 0 |
| Cash | DKK 76k | – |
| Short-term debt | DKK 83k | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Grant Thornton, Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2018 – 31 Dec 2018 | 141 | ||
| 26 Jan 2017 – 31 Dec 2017 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Søren Bay Ramsdahl | ||
| CEO | Jeppe Dyrberg Andersen | ||
| Owner (50%) | Dyrberg Andersen Holding IVS | ||
| Owner (50%) | Bay Ramsdahl Holding IVS | ||
| Founder | Dyrberg Andersen Holding IVS | ||
| Founder | Bay Ramsdahl Holding IVS |
The CEOs' other companies
Søren Bay Ramsdahl – 2 other companies
- Bo-To Ejendomme Tørring ApS Active
- DOMUS AXEL A/S Active
Jeppe Dyrberg Andersen – 1 other companies, of which 1 bankrupt
- Dyrberg Andersen Holding IVS Bankrupt 17 Oct 2019
Address history (1 moves)
| Morsøvej 44, 2720 Vanløse | |
| Frederiksvej 12, 2000 Frederiksberg |
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Fjord Pharmaceuticals IVS
Has Fjord Pharmaceuticals IVS gone bankrupt?
Yes. Fjord Pharmaceuticals IVS went bankrupt on 5 February 2021.
Who is the auditor of Fjord Pharmaceuticals IVS?
Fjord Pharmaceuticals IVS most recently used Grant Thornton, Statsautoriseret Revisionspartnerselskab.
When was Fjord Pharmaceuticals IVS founded?
Fjord Pharmaceuticals IVS was founded on 26 January 2017.
What is the equity of Fjord Pharmaceuticals IVS?
Equity was DKK -7,019 according to the annual report for the period ending 31 December 2018.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.